Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Cleveland Research Downgrades Target to Neutral

Cleveland Research Downgrades Target to Neutral

Cleveland Research downgrades Target (NYSE:TGT) from Buy to Neutral.

byBenzinga Newsdesk

December 12, 2022

1 minute read

Cleveland Research downgrades Target (NYSE:TGT) from Buy to Neutral.

Copper Prices Approach 2-Year Highs: What’s Behind Analyst’s $12,000 Price Prediction For 2026?

By Stjepan Kalinic

April 23, 4:24 PM

Copper prices have surged due to increased demand from electric vehicles, AI, and power infrastructure. Analysts predict a supply deficit and potential for even higher prices.

NGLOY

Analyst Ratings

Where Ovintiv Stands With Analysts

By Benzinga Insights

December 14, 3:00 PM

Over the past 3 months, 9 analysts have published their opinion on Ovintiv (NYSE:OVV) stock. These analysts are…

OVV

Raymond James Maintains Outperform on Dyne Therapeutics, Raises Price Target to $16

By Benzinga Newsdesk

November 4, 5:22 AM

Raymond James analyst Steven Seedhouse maintains Dyne Therapeutics (NASDAQ:DYN) with a Outperform and raises the price target from $15 to $16.

DYN

Movers
News

What’s Going On With Nio Stock?

By Erica Kollmann

August 28, 10:40 AM

NIO Inc. (NYSE: NIO) shares are moving on Monday. The stock is down more than 8% over the last month.

NIO

Cleveland Research Downgrades Target to Neutral

Related Posts

Copper Prices Approach 2-Year Highs: What’s Behind Analyst’s $12,000 Price Prediction For 2026?

Where Ovintiv Stands With Analysts

Raymond James Maintains Outperform on Dyne Therapeutics, Raises Price Target to $16

What’s Going On With Nio Stock?